{
    "Trade/Device Name(s)": [
        "Elecsys HSV-2 IgG (08948887160)"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K220924",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121895"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYF"
    ],
    "Summary Letter Date": "March 29, 2022",
    "Summary Letter Received Date": "March 31, 2022",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes simplex virus serological assays"
    ],
    "Analyte Class(es)": [
        "serology",
        "virology",
        "immunology"
    ],
    "Analyte(s)": [
        "IgG class antibodies to HSV-2"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium-heparin plasma",
        "K2-EDTA plasma",
        "K3-EDTA plasma"
    ],
    "Specimen Container(s)": [
        "Lithium-heparin tube",
        "K2-EDTA tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas e immunoassay analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Electrochemiluminescence detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys HSV-2 IgG assay to qualitatively detect IgG antibodies to HSV-2 in serum and plasma using ECLIA on cobas e analyzers",
    "Indications for Use Summary": "Intended for in vitro qualitative determination of IgG class antibodies to HSV-2 in human serum and specified plasma types as an aid in presumptive diagnosis of HSV-2 infection in sexually active individuals and expectant mothers",
    "fda_folder": "Microbiology"
}